PARP16 and Alzheimer disease: To functionally test the relevance of chronic PARP16 activation in AD pathogenesis, we performed extensive studies using AAV-mediated knockdown of PARP16 in the APP/PS1 mouse model, in which abundant Aβ plaques and deficits in spatial learning were clearly visible.